Title : Insulin activates RSK (p90 ribosomal S6 kinase) to trigger a new negative feedback loop that regulates insulin signaling for glucose metabolism.

Pub. Date : 2013 Oct 25

PMID : 24036112






8 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 We previously demonstrated that the mTORC1/S6K1 pathway is activated by insulin and nutrient overload (e.g. amino acids (AA)), which leads to the inhibition of the PI3K/Akt pathway via the inhibitory serine phosphorylation of IRS-1, notably on serine 1101 (Ser-1101). Serine insulin receptor substrate 1 Rattus norvegicus
2 We previously demonstrated that the mTORC1/S6K1 pathway is activated by insulin and nutrient overload (e.g. amino acids (AA)), which leads to the inhibition of the PI3K/Akt pathway via the inhibitory serine phosphorylation of IRS-1, notably on serine 1101 (Ser-1101). Serine insulin receptor substrate 1 Rattus norvegicus
3 We previously demonstrated that the mTORC1/S6K1 pathway is activated by insulin and nutrient overload (e.g. amino acids (AA)), which leads to the inhibition of the PI3K/Akt pathway via the inhibitory serine phosphorylation of IRS-1, notably on serine 1101 (Ser-1101). Serine insulin receptor substrate 1 Rattus norvegicus
4 However, even in the absence of AA, insulin can still promote IRS-1 Ser-1101 phosphorylation by other kinases that remain to be fully characterized. Serine insulin receptor substrate 1 Rattus norvegicus
5 Computational analyses revealed that Ser-1101 within IRS-1 falls into the consensus motif of RSK. Serine insulin receptor substrate 1 Rattus norvegicus
6 Moreover, recombinant RSK phosphorylated IRS-1 C-terminal fragment on Ser-1101, which was prevented by mutations of this site or when a kinase-inactive mutant of RSK was used. Serine insulin receptor substrate 1 Rattus norvegicus
7 Inhibition of RSK using either the pharmacological inhibitor BI-D1870 or after adenoviral expression of a dominant negative RSK1 mutant (RSK1-DN) showed that RSK selectively phosphorylates IRS-1 on Ser-1101. Serine insulin receptor substrate 1 Rattus norvegicus
8 These results show that RSK is a novel regulator of insulin signaling and glucose metabolism and a potential mediator of insulin resistance, notably through the negative phosphorylation of IRS-1 on Ser-1101. Serine insulin receptor substrate 1 Rattus norvegicus